Abstract:Background: Congenital myopathies are severe genetic diseases with a strong impact on patient autonomy and often on survival. A large number of patients do not have a genetic diagnosis, precluding genetic counseling and appropriate clinical management. Our objective was to find novel pathogenic variants and genes associated with congenital myopathies and to decrease diagnostic odysseys and dead-end. Methods: To identify pathogenic variants and genes implicated in congenital myopathies, we established and conducted the MYOCAPTURE project from 2009 to 2018 to perform exome sequencing in a large cohort of 310 families partially excluded for the main known genes. Results: Pathogenic variants were identified in 156 families (50%), among which 123 families (40%) had a conclusive diagnosis. Only 44 (36%) of the resolved cases were linked to a known myopathy gene with the corresponding phenotype, while 55 (44%) were linked to pathogenic variants in a known myopathy gene with atypical signs, highlighting that most genetic diagnosis could not be anticipated based on clinical-histological assessments in this cohort. An important phenotypic and genetic heterogeneity was observed for the different genes and for the different congenital myopathy subtypes, respectively. In addition, we identified 14 new myopathy genes not previously associated with muscle diseases (20% of all diagnosed cases) that we previously reported in the literature, revealing novel pathomechanisms and potential therapeutic targets. Conclusions: Overall, this approach illustrates the importance of massive parallel gene sequencing as a comprehensive tool for establishing a molecular diagnosis for families with congenital myopathies. It also emphasizes the contribution of clinical data, histological findings on muscle biopsies, and the availability of DNA samples from additional family members to the diagnostic success rate. This study facilitated and accelerated the genetic diagnosis of congenital myopathies, improved health care for several patients, and opened novel perspectives for either repurposing of existing molecules or the development of novel treatments.

Comprehensive Detection of Genes Causing a Phenotype Using Phenotype Sequencing and Pathway Analysis

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

From Phenotype to Gene: Detecting Disease-Specific Gene Functional Modules Via A Text-Based Human Disease Phenotype Network Construction

Identification of Genetic Elements in Metabolism by High-Throughput Mouse Phenotyping

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Novel genetic associations with serum level metabolites identified by phenotype set enrichment analyses.

A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations

Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics

Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging

A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes

Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome

Gene and Pathway-Based Analysis: Second Wave of Genome-wide Association Studies

Uncover Disease Genes by Maximizing Information Flow in the Phenome-Interactome Network.

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases

An Integrative Approach for Causal Gene Identification and Gene Regulatory Pathway Inference

Discovering Genetic Modulators of the Protein Homeostasis System through Multilevel Analysis

Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets

An Integrated Systems Genetics and Omics Toolkit to Probe Gene Function

Exome sequencing in undiagnosed congenital myopathy reveals new genes and refines genes-phenotypes correlations

The use of whole-exome sequencing to disentangle complex phenotypes